Docebo price target raised to $50 from $40 at Canaccord

Canaccord analyst Robert Young raised the firm’s price target on Docebo to $50 from $40 and keeps a Buy rating on the shares. The analyst said they reported a strong Q4 with in-line revenue and a beat on EBITDA and ARR. It also provided Q1 guidance for the first time, with revenue growth at the midpoint and 4-5% EBITDA margins, in line with consensus estimates.